|
1
|
Occult hepatitis B virus infection in patients with autoimmune liver diseases.
|
Liver Int
|
2008
|
1.76
|
|
2
|
Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
|
J Hepatol
|
2011
|
1.56
|
|
3
|
Twin studies in autoimmune disease: genetics, gender and environment.
|
J Autoimmun
|
2011
|
1.48
|
|
4
|
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
|
Gastroenterology
|
2002
|
1.41
|
|
5
|
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
|
Hepatology
|
2005
|
1.03
|
|
6
|
The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders.
|
J Autoimmune Dis
|
2007
|
1.02
|
|
7
|
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.
|
Autoimmun Rev
|
2011
|
1.01
|
|
8
|
Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes.
|
Diabetes Res Clin Pract
|
2006
|
0.97
|
|
9
|
Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
|
J Clin Immunol
|
2007
|
0.93
|
|
10
|
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.
|
World J Gastroenterol
|
2010
|
0.92
|
|
11
|
Salmonella enteritidis Infection Complicated by Acute Myocarditis: A Case Report and Review of the Literature.
|
Cardiol Res Pract
|
2011
|
0.92
|
|
12
|
IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
|
J Clin Immunol
|
2008
|
0.91
|
|
13
|
Autoimmunity and environment: am I at risk?
|
Clin Rev Allergy Immunol
|
2012
|
0.91
|
|
14
|
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
|
Hepatology
|
2007
|
0.90
|
|
15
|
Primary biliary cirrhosis: family stories.
|
Autoimmune Dis
|
2011
|
0.89
|
|
16
|
Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
|
J Autoimmun
|
2005
|
0.89
|
|
17
|
Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside.
|
Clin Res Hepatol Gastroenterol
|
2011
|
0.89
|
|
18
|
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis.
|
J Autoimmun
|
2004
|
0.87
|
|
19
|
Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
|
Am J Gastroenterol
|
2008
|
0.86
|
|
20
|
Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.
|
Clin Dev Immunol
|
2012
|
0.85
|
|
21
|
Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?
|
Dig Liver Dis
|
2010
|
0.85
|
|
22
|
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.
|
Immun Ageing
|
2011
|
0.84
|
|
23
|
Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature.
|
Liver Int
|
2007
|
0.83
|
|
24
|
PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York.
|
Dis Markers
|
2010
|
0.82
|
|
25
|
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis.
|
J Hepatol
|
2006
|
0.82
|
|
26
|
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.
|
Int J Rheumatol
|
2011
|
0.81
|
|
27
|
Infectome: a platform to trace infectious triggers of autoimmunity.
|
Autoimmun Rev
|
2012
|
0.81
|
|
28
|
p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris.
|
Autoimmun Rev
|
2012
|
0.81
|
|
29
|
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
|
Clin Chim Acta
|
2012
|
0.81
|
|
30
|
The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis.
|
Clin Dev Immunol
|
2013
|
0.81
|
|
31
|
p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity.
|
Autoimmune Dis
|
2013
|
0.81
|
|
32
|
Sex differences associated with primary biliary cirrhosis.
|
Clin Dev Immunol
|
2012
|
0.80
|
|
33
|
Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen.
|
Clin Chim Acta
|
2006
|
0.80
|
|
34
|
Oxidative stress and antioxidant status in patients with autoimmune liver diseases.
|
Redox Rep
|
2014
|
0.80
|
|
35
|
Reactivation of resolved hepatitis B virus infection after immunosuppression: is it time to adopt pre-emptive therapy?
|
Clin Res Hepatol Gastroenterol
|
2011
|
0.80
|
|
36
|
Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis.
|
Ann Hepatol
|
2011
|
0.80
|
|
37
|
Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis.
|
Clin Chim Acta
|
2009
|
0.79
|
|
38
|
Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?
|
J Gastroenterol Hepatol
|
2007
|
0.79
|
|
39
|
Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New?
|
Curr Infect Dis Rep
|
2013
|
0.79
|
|
40
|
Tracing environmental markers of autoimmunity: introducing the infectome.
|
Immunol Res
|
2013
|
0.78
|
|
41
|
Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.
|
J Hepatol
|
2005
|
0.78
|
|
42
|
CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases.
|
Clin Dev Immunol
|
2013
|
0.77
|
|
43
|
Can mathematical models be useful in clinical hepatology?
|
Liver Int
|
2010
|
0.77
|
|
44
|
Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?
|
Arthritis
|
2012
|
0.77
|
|
45
|
Autoantibodies in autoimmune pancreatitis.
|
Int J Rheumatol
|
2012
|
0.77
|
|
46
|
Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases.
|
Methods Mol Biol
|
2012
|
0.77
|
|
47
|
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?
|
World J Gastroenterol
|
2012
|
0.76
|
|
48
|
Self-mimicking autoimmune domains of hepatitis C virus core antigen.
|
Vaccine
|
2006
|
0.76
|
|
49
|
Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features.
|
Am J Kidney Dis
|
2005
|
0.75
|
|
50
|
Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: implications for the pathogenesis of the human disease.
|
Autoimmunity
|
2013
|
0.75
|
|
51
|
How common are connective tissue disorders in patients with autoimmune hepatitis?
|
Semin Arthritis Rheum
|
2007
|
0.75
|
|
52
|
Autoimmune hepatitis: of host and pathogen.
|
Hepatology
|
2008
|
0.75
|
|
53
|
Redesigning training for internal medicine.
|
Ann Intern Med
|
2006
|
0.75
|
|
54
|
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature.
|
Tuberc Res Treat
|
2012
|
0.75
|
|
55
|
Bone marrow findings in patients with autoimmune liver diseases.
|
J Gastroenterol Hepatol
|
2008
|
0.75
|